IDEXX Laboratories Inc. (IDXX) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
IDEXX Laboratories Inc. (IDXX) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (62% profit margin, 30% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
How IDXX Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $4.30B | 61.8% | 31.6% | $1.06B | $1.06B | 59.7% |
| FY 2024 | $3.90B | 61% | 29% | $887.9M | $808.1M | 50.7% |
| FY 2023 | $3.66B | 44% | 30% | $845.0M | $741.8M | 5.7% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring IDXX)
- ✓Live walkthrough of IDXX's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
IDXX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +10.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on IDXX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for IDXX. Explore sector supply chains on /butterfly.
IDXX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is IDEXX Laboratories Inc. (IDXX)?
In FY 2025 (10-K), IDXX converted $4.3B of revenue into a 61.8% gross margin, 31.6% operating margin, and $1.1B in free cash flow (24.6% FCF margin).